Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2026-02-17 @ 10:37 PM
Study NCT ID:
NCT02518958
Status:
COMPLETED
Last Update Posted:
2019-11-18
First Post:
2015-08-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab
Sponsor:
EpicentRx, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RRx001-14-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None